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The NIMA kinase joins forces with Cdc2
The NIMA and Cdc2 protein kinases cooperate to
regulate mitosis in Aspergillus nidulans. NIMA-related
pathways have now begun to emerge in higher eukaryotes.
Mitosis, the cellular process by which duplicated chromo-
somes are evenly segregated, ensures that each daughter
cell receives a complete copy of the genome. A corner-
stone in our understanding of this critical process is the
Cdc2 protein kinase. This kinase, composed of the
p34cdc2 catalytic subunit and a B-type cyclin regulatory
subunit, is the prototype for a family of cyclin-dependent
kinases (CDKs) required for cell-cycle progression in all
eukaryotes [1,2]. Intriguingly, in the filamentous fungus
Aspergillus nidulans, a second protein kinase, NIMA, is
also required for mitotic progression [3]. At first sight,
NIMA appeared to lie on a pathway independent of
Cdc2, but recent developments suggest that the two
pathways are interlinked. Furthermore, evidence is now
emerging that Cdc2 and NIMA may also coordinately
regulate mitosis in higher eukaryotes.
Cooperative regulation of mitosis by NIMA and Cdc2
Genetic screens in Aspergillus nidulans identified two
categories of mitotic mutants: those that remained
blocked in the G2 phase of the cell cycle and were not
able to enter mitosis, called nim mutants (for 'never in
mitosis'), and those that became stuck in mitosis and
were unable to proceed further, called bim mutants (for
'blocked in mitosis') [4]. Several of the corresponding
genes were subsequently shown to take part in the
mitotic pathway that includes Cdc2, but there were a few
genes whose link to Cdc2 was not immediately apparent.
Notably, mutation of one such gene, nimA, led to an
arrest of the cell cycle in G2 despite the normal activa-
tion of Cdc2 [3]. Conversely, a mutation in a gene
required for Cdc2 activation (the Aspergillus homologue
of the Cdc25 phosphatase; see Fig. la) led to an arrest in
G2, even though NIMA was at least partially active [3].
These results were originally interpreted as indicating
that NIMA and Cdc2 might lie on independent and
parallel pathways for mitotic regulation, but this sugges-
tion was difficult to reconcile with the prevailing view
that activation of Cdc2 is sufficient to trigger mitosis in
most experimental systems.
Recent work from the Osmani laboratory [5] now brings
NIMA into the Cdc2 paradigm, by suggesting that the
two pathways may converge after all, with NIMA
possibly being a substrate of the Cdc2 kinase. The
updated model places NIMA downstream of Cdc2.
Specifically, it is proposed that NIMA activation requires
two steps (Fig. la). In the first, NIMA is phosphorylated
either through autophosphorylation or by an as yet
unidentified kinase; in the second, it is further
phosphorylated by Cdc2, presumably on one or several
of the seven putative Cdc2 target sites identified in its
carboxy-terminal non-catalytic domain (Fig. c). The
first, Cdc2-independent phosphorylation step generates a
protein that is at least partially active [6], and the second,
Cdc2-dependent, phosphorylation leads to further acti-
vation of NIMA [5]. This model raises new questions as
to the exact nature of the dependency of the two
enzymes on each other. In particular, it will be important
to determine to what extent Cdc2 acts through NIMA
and, conversely, whether partially activated NIMA can
act on its substrates before being hyperphosphorylated by
Cdc2. Also, it remains to be examined whether or not
Cdc2 phosphorylates NIMA directly in vivo or operates
through an intermediate kinase, and whether this phos-
phorylation modulates only the kinase activity of NIMA
or also influences its subcellular localization or stability.
It is interesting to compare the effects of overexpressing
either the Cdc2 or the NIMA kinase. Massive over-
expression of NIMA was reported to lead to mitotic
induction in Aspergillus, regardless of the cell's position in
the cell cycle, suggesting that the proposed hyperphos-
phorylation of NIMA by Cdc2 is not necessary in this
experimental setting [7]. Conversely, dominant-negative
mutants of NIMA induced a G2-phase arrest in HeLa
cells [8], but this arrest could be overcome by a constitu-
tively active Cdc2 mutant [9]. Interpretation of over-
expression experiments is difficult, however, and the
above results may not reflect the interdependence of the
pathways under physiological conditions. In particular,
NIMA appears to be present at very low abundance in
vivo [6,10], and stimulation by Cdc2 phosphorylation may
be required to generate NIMA activities approaching the
levels obtained through overexpression. Thus, although
overexpression of either one of the two kinases appears to
be able to promote certain aspects of mitosis, the recent
work in Aspergillus would suggest that, under physio-
logical conditions, NIMA and Cdc2 may act in concert.
A role for NIMA in chromatin condensation?
Two studies have now shown that NIMA overexpression
can cause chromatin condensation, not only in Aspergillus
but also in fission yeast, Xenopus oocytes and human cells
[9,10]. It will be important to determine by what mecha-
nism(s) elevated NIMA activity causes chromatin con-
densation, and the precise relationship of the observed
phenomena to bona fide mitotic events remains to be
defined. In particular, there were no signs of mitotic
spindle formation in Xenopus, yeast or human cells
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Fig. 1. Regulation of mitotic entry and exit involves both the NIMA and Cdc2 protein kinases. (a) A model in which activation of both
NIMA and the Cdc2-cyclin B complex is necessary to allow cells to enter mitosis. Activation of Cdc2-cyclin B occurs through dephos-
phorylation of critical sites by the Cdc25 phosphatase; activation of NIMA is proposed to occur by two steps of phosphorylation, the
second of which seems to be dependent on active Cdc2, providing a point of convergence for the two pathways. (b) Exit from mitosis
into G1 requires inactivation of the two kinases, probably as a result of degradation of NIMA and cyclin B. Cyclin B is degraded at
about the metaphase-to-anaphase transition, but NIMA protein disappears later. Cyclin destruction is regulated by poly-ubiquitination,
but the disappearance of NIMA remains to be explained, and might result principally from a transient arrest in synthesis. (c) Sequence
analysis and experiments with nimA mutants have revealed several distinct domains within the NIMA protein.
expressing elevated levels of NIMA kinase activity [9,10].
In HeLa cells and Xenopus oocytes, NIMA-induced
chromatin condensation was accompanied by nuclear
envelope breakdown and disappearance of the nuclear
lamina [9]. However, no biochemical studies have been
performed to determine whether the nuclear lamina was
depolymerized through phosphorylation, which would
be indicative of a mitotic event, or degraded through
proteolysis, indicative of apoptosis [10]. Thus, at this
stage, chromatin condensation is the only process
reproducibly associated with NIMA overexpression.
The carboxyl terminus of NIMA is rich in regulatory motifs
NIMA is a 79 kDa protein with a serine/threonine-
specific kinase domain at the amino terminus and a
carboxy-terminal domain that has been shown to confer
multiple levels of regulation on the kinase (Fig. c). As
mentioned above, phosphorylation of the putative p34cdc2
sites contained within this region is likely to explain the
mitotic hyperphosphorylation and maximal activation of
NIMA. Structural motifs in the carboxyl terminus also
account, at least in part, for the observed cell-cycle-
dependent expression of NIMA; the kinase activity of
NIMA is low in G1 but increases through S and G2 to
reach maximal levels in mitosis [6]. Furthermore, the
NIMA protein was shown to accumulate when cells were
arrested in G2, but to disappear as they traversed mitosis
[5]. Two groups have shown independently that large
truncations of the carboxy-terminal domain stabilize the
NIMA protein [10,11]. These truncations remove not
only the putative Cdc2 phosphorylation sites but also
several 'PEST' sequences (rich in proline, glutamic acid,
serine and threonine), which may be responsible for
conferring a short half-life on the wild-type protein (Fig.
1c). The accumulation of stable truncated mutant NIMA
proteins led to a mitotic arrest in Aspergillus, indicating
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that reducing the level of NIMA is necessary for exit
from mitosis [11]. This is reminiscent of the situation for
cyclin B, which is expressed in a similar cell-cycle-depen-
dent manner and causes a mitotic arrest when expressed
as a non-destructible mutant. Interestingly, the mitotic
arrest induced by stable NIMA proteins occurred despite
the normal proteolysis of cyclin B. It is possible, but
remains to be proven, that NIMA may be part of a grow-
ing family of proteins that need to be destroyed, in addi-
tion to cyclin B, in order for cells to exit mitosis (Fig. lb).
Expression of the carboxy-terminal domain of NIMA by
itself produces a dominant-negative phenotype, inducing
a G2 arrest in both Aspergillus and HeLa cells [8,9]. Dele-
tion studies have revealed a specific stretch of approxi-
mately 100 amino acids at the beginning of the
carboxy-terminal domain which is required for the
nuclear localization of NIMA and necessary for the dom-
inant-negative G2 arrest phenotype [9]. This sequence
shows significant homology to coiled-coil domains and
might be important for targeting NIMA to substrates or
to specific subcellular compartments through
protein-protein interactions (Fig. c). Thus, the carboxy-
terminal domain of NIMA appears to control the activa-
tion, stability and localization of the kinase, thereby
performing very similar functions to those attributed to
the cyclin moiety within the p34,dc2-cyclin B complex.
Identification of Neks, mammalian NIMA-related kinases
As described above, overexpression of NIMA leads to
premature chromatin condensation in a wide range
of eukaryotic cells. Additional evidence that NIMA
pathways exist in higher eukaryotes has come from the
demonstration that dominant-negative mutants of nimA
can induce a dose-dependent G2 arrest in HeLa cells [9].
Taken together, these results provide good reasons to pre-
dict that homologues of nimA are likely to be found in
other organisms, including metazoans. The only species
for which a genuine functional homologue of nimA has
so far been identified is another filamentous fungus,
Neurospora crassa [12], but genes encoding protein kinases
structurally related to NIMA have been cloned from
yeast and trypanosomes, as well as from higher eukary-
otes. In particular, several full-length or partial Nek
(NIMA-related kinase) cDNAs have been isolated in
mammals [9, 13-15] suggesting the existence of a whole
family of NIMA-related kinases. By analogy to the
various CDK-cyclin complexes, different Nek family
members may function during different phases of the cell
cycle or in different tissues.
At present, the best characterized of these proteins is the
human Nek2. Of all NIMA-related kinases, Nek2 shares
the greatest sequence similarity with NIMA, being 47 %
identical over the catalytic domain [15]. Moreover,
despite a lack of sequence conservation beyond the
catalytic domain, Nek2 also contains a coiled-coil motif
at the beginning of its carboxy-terminal domain (A.E and
E.N., unpublished observations). In addition, the sub-
strate specificity in vitro and biochemical properties of
Nek2 are reminiscent of NIMA [16], and Nek2 protein
levels and activity are regulated through the cell cycle
[15,16]. But significant differences do exist between
NIMA and Nek2: most notably, whereas NIMA activity
peaks in mitosis [6], Nek2 activity peaks in S/G2 phase
and is low when cells are in mitosis [16]. Also, Nek2 con-
tains none of the putative Cdc2 phosphorylation sites or
PEST motifs identified in the carboxyl terminus of
NIMA. These data suggest that Nek2 might function
earlier in the cell cycle than NIMA, and perhaps another
Nek family member is required to perform the purported
mitotic function of NIMA. Indeed, overexpression of
Nek2 does not appear to lead to any detectable mitotic
phenotype (A.E and E.N., unpublished results, and [9]).
On the other hand, it should be kept in mind that
Aspergillus has a 'closed' mitosis, in which the nuclear
envelope does not break down; hence, the regulation of
mammalian NIMA homologues in both time and space
may be different from the situation in Aspergillus.
In conclusion, there are now good indications that
NIMA pathways may exist beyond Aspergillus. Several
candidate vertebrate homologues of NIMA have already
been identified, but others may remain to be found. At
this stage, it is important to determine in what capacity
Nek2 and its fellow family members contribute to cell-
cycle regulation in vertebrate cells, and how they interact
with the ever-growing panoply of CDK-cyclin com-
plexes. The latest studies with the Aspergillus NIMA pro-
tein discussed here have provided sufficient clues to make
those working in this field confident that they will soon
move closer to the mainstream of cell-cycle research.
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